Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-15

FDA Approved: RIVAROXABAN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's original application for generic rivaroxaban, a direct oral anticoagulant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)